Related Experiment Video
Updated: Aug 8, 2026

13:04
A Protocol for Analyzing Hepatitis C Virus Replication
Published on: June 26, 2014
Development and maintenance of a community-based hepatitis C registry
Barbara P Yawn1, Lilliana Gazzuola, Peter C Wollan
1Department of Clinical Research, Olmsted Medical Center, Rochester, MN 55904, USA. yawnx002@tc.umn.edu
The American Journal of Managed Care
|March 28, 2002
Summary
Developing a hepatitis C patient registry requires both diagnostic summaries and laboratory data for accurate identification. This model aids clinical care and epidemiological studies for hepatitis C patients.
Area of Science:
- Public Health
- Epidemiology
- Health Informatics
Background:
- Hepatitis C (HCV) poses a significant public health challenge, necessitating robust methods for patient identification and management.
- Effective clinical care and epidemiological studies depend on comprehensive registries of diagnosed individuals.
Purpose of the Study:
- To develop and test a model for creating community-based registries of patients diagnosed with hepatitis C.
- To facilitate improved clinical care and support epidemiologic research for hepatitis C.
Main Methods:
- A geographically defined, population-based cohort study utilizing data from the Rochester Epidemiology Project (REP) from 1990-1999.
- Supplementation of diagnostic data with Olmsted County laboratory records for hepatitis C testing.
- Medical record review for confirmation of diagnoses and testing of proposed registry data elements.
Main Results:
- Identified 355 subjects with hepatitis C in a population of 130,000, with 87% from diagnostic summaries and 13% from laboratory data.
- Confirmed the importance of both diagnostic and laboratory databases for comprehensive subject identification.
- Found that most required data elements were available in medical records, with minimal refusal for authorization.
Conclusions:
- Integrated use of medical visit diagnostic summaries and laboratory databases is essential for identifying hepatitis C patients.
- The developed model demonstrates feasibility for establishing hepatitis C registries.
- Minimal patient refusal suggests acceptance of data collection for research purposes.
Related Concept Videos
Healthcare Associated Infections II: Preventive Measures
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Chronic Pancreatitis II: Collaborative Care
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
Hepatitis
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Cirrhosis I: Introduction
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...

